Serum Interleukin-23 in Polish Patients with Systemic Lupus Erythematosus: Association with Lupus Nephritis, Obesity, and Peripheral Vascular Disease

Table 4

Classical atherosclerotic risk factors in patients with systemic lupus erythematosus and healthy controls.

Risk factor	Systemic lupus erythematosus patients; Mean ± SD; Median (Q1, Q3)	Healthy controls; Mean ± SD; Median (Q1, Q3)
Total cholesterol (mg/dL)	218.5 ± 59.8	229.3 ± 41.3
LDL cholesterol (mg/dL)	129.1 ± 47.7	139.3 ± 34.3
HDL cholesterol (mg/dL)	58.9 ± 24.5	61.3 ± 9.9
Triglycerides (mg/dL)	150.0 ± 91.2	143.7 ± 73.3
Hypertension, n (%)	37 (39.3%)	3 (11.1%)
BMI	25.5 ± 4.9	24.5 ± 3.4
Smoking habits, n (%)	31 (33.0%)	12 (44.4%)
Diabetes, n (%)	11 (11.7%)	0 (0.0%)
Oral contraceptive use, n (%)	4/82 (4.9%)	5/21 (23.8%)
Family history of cardiovascular disease, n (%)	4 (4.3%)	4 (14.8%)

LDL: low-density lipoprotein; HDL: high-density lipoprotein; BMI: body mass index.